Ardais has named Gregory Phelps CEO, the company said Jan. 20.
Phelps, 53, comes to Ardais from Dyax, where he was vice chairman and was responsible for corporate development.
“Greg is well known as an industry leader with strong business management skills, extensive operations experience, knowledge of R&D management, and expertise in the development of new products and new businesses on a global scale,” said Ardais’ Chairman Jeffrey Otten.
Third Wave Technologies has appointed Procter & Gamble veteran Gordon Brunner, 64, to its board of directors, the company announced Jan. 21.
Gordon, whose positions at P&G included senior VP, chief technology officer, head of worldwide research, and a place on the board, said “there is a global need for genetic testing products.”
Genome BioSciences has tapped John Reed to sit on its scientific advisory board, the company said Jan. 21.
Reed, 44, is president of the Burnham Institute and joins Paul Hasty of the University of Texas, San Antonio, who was the first SAB member appointed this year.